AAREYDRUGS — Aarey Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.55bn
- IN₹1.87bn
- IN₹4.74bn
- 52
- 43
- 53
- 48
Annual balance sheet for Aarey Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 71.4 | 77 | 11.2 | 28.9 | 32.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,620 | 1,363 | 2,004 | 2,000 | 1,595 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,184 | 2,263 | 2,706 | 2,826 | 2,133 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 143 | 145 | 139 | 130 | 162 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,330 | 2,452 | 2,913 | 3,033 | 2,383 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,326 | 1,301 | 1,681 | 1,665 | 969 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,342 | 1,315 | 1,739 | 1,705 | 998 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 989 | 1,136 | 1,174 | 1,328 | 1,385 |
Total Liabilities & Shareholders' Equity | 2,330 | 2,452 | 2,913 | 3,033 | 2,383 |
Total Common Shares Outstanding |